Baseline demographic, clinical and laboratory characteristics based on tertiles of Gensini score.

BMI = Body mass index; PVD = Peripheral vascular disease; CAD = Coronary artery disease; LVFE  =  Left ventricular ejection fraction; NT-pro-BNP = N-terminal pro-Brain natriuretic peptide; hs-CRP = high sensitivity C-reactive protein; N/L ratio  = Neutrophil count to lymphocyte count ratio; HbA1c = Glycosylated hemoglobinA1C; FBG = Fasting blood glucose; ALP = Alkaline phosphatase; AST = Aspartate aminotransferase; ALT = Alanine aminotransferase; TC = Total cholesterol; LDL-C = Low density lipoprotein cholesterol; HDL-C = High density lipoprotein cholesterol; ACE-I = Angiotensin converting enzyme inhibitors; ARB = Angiotensin receptor blocker.
aP-value obtained from analysis of variance, Kruskal-Wallis test, or chi-squared test.
bP-value for high GS versus non-high (low and intermediate) GS.

BMI：体重指数（Body mass index）；PVD：外周血管病（Peripheral vascular disease）；CAD：冠状动脉疾病（Coronary artery disease）；LVFE：左心室射血分数（Left ventricular ejection fraction）；NT-pro-BNP：N末端脑钠肽前体（N-terminal pro-Brain natriuretic peptide）；hs-CRP：高敏C反应蛋白（high sensitivity C-reactive protein）；N/L ratio：中性粒细胞与淋巴细胞比值（Neutrophil count to lymphocyte count ratio）；HbA1c：糖化血红蛋白A1c（Glycosylated hemoglobin A1c）；FBG：空腹血糖（Fasting blood glucose）；ALP：碱性磷酸酶（Alkaline phosphatase）；AST：天冬氨酸氨基转移酶（Aspartate aminotransferase）；ALT：丙氨酸氨基转移酶（Alanine aminotransferase）；TC：总胆固醇（Total cholesterol）；LDL-C：低密度脂蛋白胆固醇（Low density lipoprotein cholesterol）；HDL-C：高密度脂蛋白胆固醇（High density lipoprotein cholesterol）；ACE-I：血管紧张素转换酶抑制剂（Angiotensin converting enzyme inhibitors）；ARB：血管紧张素Ⅱ受体拮抗剂（Angiotensin receptor blocker）。注a：P值通过方差分析、Kruskal-Wallis检验或卡方检验计算所得。注b：高GS组与非高GS组（低GS组及中GS组）的P值。